| Pfizer Halts Heart Failure Drug Trial Early on Good News Derek Lowe submits: Pfizer (PFE) was able to announce some good news today - their trial of Inspra (eplerenone) for patients with a particular combination of heart failure symptoms. The trial was halted early, but (for once) because the endpoints were reached so early that it would have been unethical to continue the placebo arm. It's always nice to hear about one of those; we don't get them that often. The drug is an aldosterone antagonist which had already been approved several years ago for heart failure and hypertension, so it's not really a surprise that it worked in this population. But you never know, and Pfizer wanted to be able to get specifically recommended for patients of this type. And that they will.Complete Story » seekingalpha.com |
Drug Price Controls Hit Generics The Philippines use of price controls to lower the cost of life-saving medications is creating some unexpected problems—including crimping the supply of inexpensive generic drugs. online.wsj.com |
LabCorp Establishes Global Clinical Trials Collaboration with Clearstone Central Labs (Business Wire) BURLINGTON, N.C.----Laboratory Corporation of America® Holdings announced today a collaboration between Esoterix Clinical Trials Services, a division of LabCorp, and Clearstone Central Laboratories, a global central laboratory specializing in drug development and pharmaceutical services. us.rd.yahoo.com |
Enzo Biochem to Present at Two Healthcare Conferences in New York City [Business Wire] - NEW YORK----Enzo Biochem, Inc. , a leading biotechnology company specializing in gene identification and genetic and immune regulation technologies for diagnostic and therapeutic applications, announced today that Barry Weiner, President, and David Goldberg, Vice President, Corporate Development, will both be presenting at two upcoming institutional investor conferences: us.rd.yahoo.com |
Neurocrine Biosciences Seen Running Out of Gas optionMONSTER submits: By David Russell Neurocrine Biosciences (NBIX) has made a big move, and now the bulls are throwing in the towel.Complete Story » seekingalpha.com |